+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pet Contraceptive Vaccine Market by Animal Type (Cats, Dogs), Product Type (Hormonal, Non-Hormonal), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Pet Contraceptive Vaccine Market by Animal Type (Cats, Dogs), Product Type (Hormonal, Non-Hormonal), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
New

Pet Contraceptive Vaccine Market by Animal Type (Cats, Dogs), Product Type (Hormonal, Non-Hormonal), Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6134350
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Uncovering Fundamental Motivations and Core Challenges Shaping the Emergence and Adoption of Pet Contraceptive Vaccines in Veterinary Practice

The field of pet contraceptive vaccines is at an inflection point, driven by a confluence of demographic shifts, technological breakthroughs, and evolving ethical considerations in animal welfare. As the companion animal population continues to expand, veterinary professionals and pet owners alike seek alternatives to traditional surgical sterilization that offer efficacy alongside reduced invasiveness. Over recent years, research into immunocontraceptive approaches has accelerated, leveraging molecular biology innovations to inhibit fertility through targeted immune responses rather than physical intervention.

In turn, the adoption curve has risen significantly, with pilot programs in both clinical and shelter environments demonstrating promising outcomes in terms of safety, duration of effect, and cost-efficiency. Regulatory bodies have responded with conditional approvals and fast-track pathways in recognition of the animal welfare benefits and potential to relieve resource constraints in high-volume adoption centers. Against this backdrop, a holistic understanding of the drivers, barriers, and stakeholder priorities is essential for any organization aiming to influence product development, policy advocacy, or market positioning.

Navigating Vital Transformations and Technological Innovations Revolutionizing How Veterinary Professionals and Pet Owners Approach Contraception for Companion Animals

Recent advances have redefined the landscape of pet contraception, ushering in an era where biotechnology converges with veterinary medicine to deliver novel immunocontraceptive solutions. The shift from irreversible surgical procedures toward reversible vaccine-based interventions reflects not only a technological progression but also a cultural transformation in how caregivers approach reproductive management. Darkfield imaging, next-generation sequencing, and predictive analytics have combined to streamline antigen selection and enhance vaccine safety profiles, enabling a new generation of targeted molecules that elicit specific antibody responses without off-target effects.

Furthermore, digital platforms have emerged to support vaccine administration, tracking dosing schedules, and monitoring long-term efficacy, enabling veterinarians to adopt data-driven approaches to companion animal health. Public-private partnerships have accelerated translational research, while philanthropic initiatives have fueled field trials in underserved regions. Collectively, these developments are transforming both supply chain paradigms and end-user engagement, laying the groundwork for widespread acceptance of non-surgical reproductive control in cats and dogs alike.

Assessing the Far-Reaching Consequences of United States Tariff Modifications on Costs, Accessibility, and Supply Chains within the Pet Contraceptive Vaccine Sector

In 2025, adjustments to United States tariff policy have produced significant downstream effects on the pet contraceptive vaccine sector. New import duties applied to biobased components-ranging from recombinant proteins to specialized adjuvants-have introduced cost pressures across the production continuum. Manufacturers are encountering increased expenses for critical raw materials sourced from international suppliers operating in established biotech hubs, compelling a reevaluation of procurement strategies.

The imposition of tariffs has also affected logistical frameworks, as distribution partners adapt to altered duty structures and shifting freight dynamics. Some organizations have begun exploring localized manufacturing arrangements to mitigate exposure to tariff fluctuations and streamline compliance. At the same time, clinics and end users face potential price adjustments that could influence adoption rates unless counterbalanced by targeted subsidy programs or bulk purchasing agreements.

Despite these headwinds, many stakeholders view the tariff landscape as an impetus for greater vertical integration and domestic capacity building. Strategic responses are emerging in the form of joint ventures with local biotech firms, investment in modular production facilities, and advocacy efforts aimed at securing tariff exemptions for essential veterinary health products.

Delivering In-Depth Segmentation Perspectives Clarifying Distinct Pet Categories Therapeutic Modalities Distribution Pathways and End User Dynamics

A nuanced evaluation of the market requires attention to multiple segmentation dimensions that define demand and influence distribution strategies. Based on animal type, the investigation covers both cats and dogs, with cat populations further categorized into indoor and outdoor segments and canine subjects analyzed by breed size, spanning large, medium, and small classifications. In parallel, product type segmentation delineates hormonal platforms-available in injectable and oral formats-and non-hormonal technologies, which include emerging DNA-based and protein-based modalities tailored to targeted immunogenic responses.

Distribution channel analysis examines the roles of online pharmacies adapting to telehealth integrations, traditional retail pharmacy networks offering comprehensive pet care portfolios, and veterinary clinics that serve as primary inoculation centers under professional supervision. Finally, end user segmentation explores the unique requirements of animal shelters, pet owners, and veterinary hospitals, each prioritizing efficacy, safety, and logistical convenience differently. By synthesizing these dimensions, organizations can pinpoint high-value intersections, refine product positioning, and tailor outreach to distinct stakeholder groups.

Unveiling Critical Regional Dynamics Highlighting Key Growth Drivers Challenges and Market Adaptations across the Americas Europe Middle East Africa and Asia Pacific

Regional market dynamics reveal divergent drivers and adoption patterns across the Americas, Europe Middle East and Africa, and Asia Pacific. In the Americas, a well-established pet care infrastructure coupled with robust veterinary associations facilitates rapid awareness campaigns, while philanthropic collaborations support trials in high-density urban shelters. Regulatory frameworks in North America are characterized by conditional approvals and post-market surveillance requirements that encourage incremental innovation.

Across Europe, the Middle East and Africa, market participants navigate a tapestry of localized regulatory regimes and varying levels of veterinary care accessibility. Established markets in Western Europe demonstrate high receptivity to immunocontraceptive solutions, buoyed by public awareness of humane population control, whereas emerging markets in the Middle East and Africa exhibit uneven infrastructure but significant potential for pilot programs supported by international NGOs.

In Asia Pacific, accelerating pet adoption trends and expanding consumer spending on animal wellness are powerful catalysts. Diverse regulatory environments range from stringent approvals in Japan and Australia to evolving frameworks in Southeast Asia that are increasingly receptive to non-surgical alternatives. Supply chain optimization and targeted local partnerships remain central to unlocking these regional opportunities.

Profiling Influential Industry Participants Highlighting Strategic Initiatives Competitive Differentiators and Collaborative Efforts Driving Advances in Pet Contraceptive Vaccines

Leading organizations occupy distinct positions along the innovation spectrum, leveraging strategic alliances, patent portfolios, and clinical trial data to secure competitive advantage. Some pioneers have forged partnerships with academic research institutes to advance novel antigen discovery, while others focus on scaling established injectable formulations through expanded production networks. A number of companies emphasize proprietary adjuvant technologies that enhance immunogenicity and extend duration of effect, differentiating their platforms in an increasingly crowded field.

Collaboration with contract development and manufacturing organizations has become a prevalent strategy, enabling agile scale-up while maintaining rigorous quality standards. Meanwhile, a subset of specialized players is exploring bioconjugation techniques that promise enhanced specificity, presenting potential entry points for startups with niche expertise. Across the spectrum, cross-sector alliances-spanning animal health, biotech, and digital health-are driving integrative solutions that pair vaccine administration with monitoring and compliance tools. This ecosystem approach underscores the importance of both horizontal and vertical integration when navigating complex regulatory and logistical landscapes.

Proposing Concrete Strategic Pathways Enabling Industry Leaders to Navigate Regulatory Complexities Enhance Product Reach and Capitalize on Emerging Market Opportunities

Industry leaders seeking to maximize impact should prioritize a multifaceted strategy that aligns scientific innovation with market realities. First, early engagement with regulatory authorities can expedite approval pathways and clarify post-market data requirements, reducing time to market. Simultaneously, investing in scalable and modular manufacturing capabilities will mitigate exposure to supply chain disruptions and shifting tariff regimes.

Emphasis on strategic partnerships across academic, nonprofit, and commercial entities can accelerate antigen development and share the burden of clinical validation. To cultivate end-user trust, integrated educational campaigns must underscore safety profiles and long-term benefits, leveraging digital platforms for targeted outreach to both veterinary professionals and pet owners. Moreover, flexible pricing models and subscription-based service offerings may enhance accessibility across diverse end users, from large shelters to individual households.

Finally, embedding telemetry and compliance monitoring into vaccine administration workflows promises to strengthen data-driven decision-making, supporting continuous improvement of immunocontraceptive regimens while reinforcing stakeholder confidence in product reliability and value.

Explaining Comprehensive Research Approaches Combining Qualitative Expert Interviews Quantitative Data Collection and Rigorous Analytical Frameworks to Ensure Robust Findings

This analysis integrates qualitative insights gathered through in-depth interviews with veterinary experts, shelter administrators, and industry veterans, complemented by secondary research sourced from peer-reviewed journals, regulatory filings, and corporate disclosures. Quantitative data aggregation from public health databases and patent registries provides a robust foundation for identifying innovation clusters and tracking competitive landscapes.

A triangulated validation process was employed, wherein preliminary findings were cross-checked against proprietary clinical trial summaries and field data provided by collaborating veterinary networks. The research framework is underpinned by an iterative feedback loop, ensuring that emerging trends are contextualized and corroborated by multiple stakeholder perspectives. Methodological rigor is maintained through adherence to best-practice guidelines in data ethics, transparency in sourcing, and meticulous documentation of analytical assumptions.

Summarizing Key Takeaways and Reflective Insights Illuminating Trends Learnings and Strategic Implications Derived from the Comprehensive Investigation

Through this comprehensive investigation, several overarching themes have crystallized. Technological maturation in immunocontraception is converging with growing demand for non-invasive reproductive control solutions, creating fertile ground for innovation. Tariff and regulatory shifts in key jurisdictions present both challenges and incentives for near-term strategic pivots, while segmentation analysis illuminates distinct opportunity zones across species, product modalities, channels, and end users.

Regional insights reveal that while mature markets offer streamlined pathways for adoption, emerging economies present untapped potential supported by evolving policy landscapes and philanthropic engagement. Competitive profiling underscores the importance of integrated ecosystems and advanced manufacturing capabilities to achieve differentiation. Finally, actionable recommendations emphasize proactive regulatory engagement, strategic collaborations, scalable operations, and data-driven outreach as critical levers for sustained growth.

In conclusion, stakeholders who adopt a holistic approach-balancing scientific excellence with market agility and stakeholder alignment-will be best positioned to lead the transformation of pet contraceptive vaccine deployment globally.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Cats
      • Indoor Cats
      • Outdoor Cats
    • Dogs
      • Breed Size
        • Large
        • Medium
        • Small
  • Product Type
    • Hormonal
      • Injectable
      • Oral
    • Non-Hormonal
      • DNA-Based
      • Protein-Based
  • Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies
    • Veterinary Clinics
  • End User
    • Animal Shelters
    • Pet Owners
    • Veterinary Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • HIPRA, S.A.
  • SenesTech, Inc.
  • Hester Biosciences Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of recombinant DNA technology in pet contraceptive vaccines to improve immunogenicity and reduce booster requirements
5.2. Strategic partnerships between veterinary biologics companies and animal welfare organizations to accelerate contraceptive vaccine adoption
5.3. Rising investment in peptide-based immunocontraceptive research to address safety concerns and target-specific fertility pathways
5.4. Regulatory harmonization initiatives across regions to fast-track approval of novel pet contraceptive vaccines for population control
5.5. Development of single-dose sustained-release delivery systems for pet contraceptive vaccines to improve compliance and uptake
5.6. Consumer demand for non-invasive contraceptive vaccine options driving research into needle-free administration technologies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pet Contraceptive Vaccine Market, by Animal Type
8.1. Introduction
8.2. Cats
8.2.1. Indoor Cats
8.2.2. Outdoor Cats
8.3. Dogs
8.3.1. Breed Size
8.3.1.1. Large
8.3.1.2. Medium
8.3.1.3. Small
9. Pet Contraceptive Vaccine Market, by Product Type
9.1. Introduction
9.2. Hormonal
9.2.1. Injectable
9.2.2. Oral
9.3. Non-Hormonal
9.3.1. DNA-Based
9.3.2. Protein-Based
10. Pet Contraceptive Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Online Pharmacies
10.3. Retail Pharmacies
10.4. Veterinary Clinics
11. Pet Contraceptive Vaccine Market, by End User
11.1. Introduction
11.2. Animal Shelters
11.3. Pet Owners
11.4. Veterinary Hospitals
12. Americas Pet Contraceptive Vaccine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pet Contraceptive Vaccine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pet Contraceptive Vaccine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Merck & Co., Inc.
15.3.3. Boehringer Ingelheim International GmbH
15.3.4. Elanco Animal Health Incorporated
15.3.5. Ceva Santé Animale S.A.
15.3.6. Virbac S.A.
15.3.7. Vetoquinol S.A.
15.3.8. HIPRA, S.A.
15.3.9. SenesTech, Inc.
15.3.10. Hester Biosciences Limited
16. ResearchAI17. ResearchStatistics18. ResearchContacts19. ResearchArticles20. Appendix
List of Figures
FIGURE 1. PET CONTRACEPTIVE VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PET CONTRACEPTIVE VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PET CONTRACEPTIVE VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PET CONTRACEPTIVE VACCINE MARKET: RESEARCHAI
FIGURE 24. PET CONTRACEPTIVE VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 25. PET CONTRACEPTIVE VACCINE MARKET: RESEARCHCONTACTS
FIGURE 26. PET CONTRACEPTIVE VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PET CONTRACEPTIVE VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY INDOOR CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY INDOOR CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY OUTDOOR CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY OUTDOOR CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY LARGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY LARGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY MEDIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY MEDIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY SMALL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY SMALL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DNA-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DNA-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PROTEIN-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PROTEIN-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PET OWNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 107. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 110. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 111. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 112. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 113. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 114. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 115. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 118. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 119. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 120. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 121. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 136. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 137. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 220. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 221. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 222. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 223. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 228. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 229. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 230. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 231. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. GERMANY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 236. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 238. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 239. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 240. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 241. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 246. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 247. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 248. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 249. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. FRANCE PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 272. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 273. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 274. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 275. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 276. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 277. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 278. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 279. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 282. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 283. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 284. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 285. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. ITALY PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 290. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 291. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 292. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 293. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 294. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 295. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 296. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 297. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 300. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 301. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 302. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 303. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SPAIN PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DOGS, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY BREED SIZE, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY HORMONAL, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY NON-HORMONAL, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES PET CONTRACEPTIVE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 326. SAUDI ARABIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2018-2024 (USD MILLION)
TABLE 328. SAUDI ARABIA PET CONTRACEPTIVE VACCINE MARKET SIZE, BY CATS, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pet Contraceptive Vaccine Market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • HIPRA, S.A.
  • SenesTech, Inc.
  • Hester Biosciences Limited

Related Topics

Related Reports

Pet Rabies Vaccine Antibody Testing Service Market by Animal Type (Cats, Dogs, Wildlife), Test Type (Elisa, Rapid Diagnostic Test Kits, Virus Neutralization Test), Distribution Channel, End User, Sample Type, Application, Price Range - Global Forecast 2025-2030 - Product Image

Pet Rabies Vaccine Antibody Testing Service Market by Animal Type (Cats, Dogs, Wildlife), Test Type (Elisa, Rapid Diagnostic Test Kits, Virus Neutralization Test), Distribution Channel, End User, Sample Type, Application, Price Range - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Pet Vaccines - Global Strategic Business Report - Product Image

Pet Vaccines - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Dog Vaccines Market by Vaccine Type, Technology, End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030 - Product Image

Dog Vaccines Market by Vaccine Type, Technology, End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030

  • Report
  • 195 Pages
From
Animal Pharmaceuticals Market by Product Type (Anesthetics, Anti-Inflammatory Medications, Antibiotics), Species (Aquatic Animals, Birds, Companion Animals), Route of Administration, Disease Type, End User, Distribution Channels - Global Forecast 2025-2030 - Product Image

Animal Pharmaceuticals Market by Product Type (Anesthetics, Anti-Inflammatory Medications, Antibiotics), Species (Aquatic Animals, Birds, Companion Animals), Route of Administration, Disease Type, End User, Distribution Channels - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Companion Animal Vaccine Market by Animal Type (Cats, Dogs), Vaccine Type (Inactivated, Live Attenuated, mRNA), Route Of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Companion Animal Vaccine Market by Animal Type (Cats, Dogs), Vaccine Type (Inactivated, Live Attenuated, mRNA), Route Of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.